Related Experiment Video
Updated: Jan 24, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis
Bernadette J Prentice1, Avinesh Chelliah2, Chee Y Ooi3
1Department of Respiratory Medicine, Sydney Children's Hospital, Randwick, NSW, Australia; School of Women's and Children's Health, Medicine, The University of New South Wales, Randwick, NSW, Australia; Molecular and Integrative Cystic Fibrosis Research Centre (miCF_RC), Sydney, Australia.
Insights
Peak glucose levels during an Oral Glucose Tolerance Test (OGTT) in children with Cystic Fibrosis (CF) correlate with poorer health outcomes. The standard 2-hour OGTT may miss early signs of CF-related diabetes (CFRD) in young patients.
Area of Science:
- Pediatric Endocrinology
- Cystic Fibrosis Research
- Metabolic Disorders
Background:
- Cystic Fibrosis-related diabetes (CFRD) screening is recommended for children under 10 with CF, particularly when growth and lung function are concerns.
- The Oral Glucose Tolerance Test (OGTT) is the standard diagnostic tool but lacks validation in this young pediatric cohort.
- Early detection of CFRD is crucial for managing associated health complications.
Purpose of the Study:
- To evaluate if the 2-hour OGTT accurately detects clinical decline in children under 10 with CF.
- To determine the association between different OGTT glucose measurements (peak vs. 2-hour) and clinical parameters like lung function and nutritional status.
- To compare OGTT findings with Continuous Glucose Monitoring (CGM) data in this population.
Main Methods:
- Analysis of blood glucose (BG) levels measured every 30 minutes during OGTT in 27 children with CF (<10 years old).
- Comparison of 2-hour BG (BG120min), peak BG (BGmax), and Area Under the Curve (AUC) for glucose.
- Correlation analysis of BG measurements with lung function (FEV1) and nutritional status (weight z-score).
- Comparison of OGTT results with CGM data in 11 participants.
Main Results:
- Peak BG (BGmax) was higher than BG120min in 93% of participants.
- BGmax showed a significant inverse correlation with weight z-score (rs = -0.56, p = .002) and FEV1 (rs = -0.54, p = .014).
- No significant correlation was found between BG120min and these clinical parameters.
- Fasting insulin levels inversely correlated with elevated glucose on CGM (AUC >7.8 mmol/L or % time >7.8).
Conclusions:
- Higher peak glucose levels (BGmax) during OGTT in young children with CF are associated with reduced lung function and lower weight z-scores.
- The standard 2-hour OGTT (BG120min) may not identify these early clinical declines in children under 10.
- Continuous Glucose Monitoring (CGM) can effectively detect glucose excursions in young children with CF, offering a potential alternative or supplementary monitoring tool.
Background:
Screening for Cystic Fibrosis-related diabetes is recommended in patients with CF <10 years old when there are concerns about growth and lung function. The Oral Glucose Tolerance Test (OGTT) is recommended but has not been validated in this cohort. We sought to determine whether the 2-h OGTT, the gold standard diagnostic test for CFRD, detects clinical decline in children with CF <10 years old.
Methods:
We analysed blood glucose(BG) levels collected every 30 min during OGTT in 27 children with CF < 10 years old, comparing the 2-hour BG (BG120min), peak BG (BGmax) and Area Under the Curve(AUC) for glucose and the association with lung function and nutritional status. We also compared the OGTT results with results from Continuous Glucose Monitoring (CGM) performed in 11 participants.
Results:
The BGmax was higher than the BG120min in 25/27 (93%) participants. There was a significant inverse correlation between BGmax and weight z-score (rs = -0.56, p = .002) and between BGmax and FEV1 (rs = -0.54, p = .014) that was not present for BG120min. A significant inverse correlation was also identified between fasting insulin level and elevated glucose on CGM, defined as AUC >7.8 mmol/L (rs = - 0.69, p = .027) or as % time > 7.8 (rs = - 0.76, p = .011).
Conclusions:
Children with CF < 10 years of age with higher BGmax on OGTT have lower lung function and weight z- scores that may not be identified using the 2 h OGTT BG120min. CGM also identifies glucose excursions in young children with CF.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Lung Capacity
IR Spectrum Peak Splitting: Symmetric vs Asymmetric Vibrations
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
IR Spectrum Peak Intensity: Amount of IR-Active Bonds

